Gilead Sciences · 2 days ago
Director, Marketing Strategy and Planning
San Francisco Bay Area
Full-time
Onsite
Director/Executive
$226K/yr - $293K/yr
10+ years expGilead Sciences is committed to creating a healthier world by tackling significant diseases and developing innovative therapies. The Director, Marketing Strategy and Planning will lead the launch of a groundbreaking HIV therapy, collaborating with cross-functional teams to design and execute strategic marketing initiatives.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Support launch and strategic initiatives for ISL-LEN, a novel new HIV treatment
Leads launch planning cross functional teams incl global in the development of strategic and tactical plans supporting a new launch in HIV Treatment. This will include establishing governance standards, leading and coordinating cross-functional planning team, and ensuring launch planning timelines are developed, continuously assessed, and on time
Closely collaborates with the Global ISL/LEN Commercial team and our Alliance partner to ensure US strategy is aligned to Global Commercial Strategy and joint commercialization approach
Drive Strategic Brand Communications (coordinating between our US HIV Treatment team, GCSO, Public Affairs and our Alliance partner)
Collaborate with brand leadership and cross functional team members to generate brand analytics and therapeutic insight generation such as market size and dynamics, product clinical profile, product differentiation, competitive environment, market share trends, and lifecycle plans to inform strategic brand direction
Ensures compliance with all applicable laws, regulations and regulatory guidelines governing commercial and scientific interactions with healthcare professionals, payers, advocacy and other business partners
Qualification
Required
A minimum of 5 years of brand development and marketing
Experience working on products within a portfolio a plus
Must possess excellent strategic thinking skills with ability to formulate, develop and execute strategy
Ability to translate market research findings into actionable insights and tactical plans
Strong capacity to collaborate with and lead cross-functional teams. Must work cooperatively with commercial management, medical affairs, compliance, market research and others
Ability to understand and communicate clinical data and high-level science
Demonstrated excellence in project management and effectively managing multiple projects/priorities
Ability to effectively lead agencies and other external partners on strategic and tactical projects
Firm command of financial management with an understanding of expense budget planning and tracking
Excellent communication skills (written and oral) and experience presenting to Senior Management is required
Experience in pharmaceutical strategy and planning and/or experience in pharmaceutical consulting
Bachelor's degree with at least 12 years of marketing experience, or
Master's degree or PhD with at least 10 years of marketing experience
Preferred
An MBA with 10+ years of pharma/biotech marketing experience
Experience in product launch and portfolio management
Knowledge of pharmaceutical regulatory requirements impacting marketing messaging and materials
Prior experience with advertising, digital, or communications agencies is advantageous
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
10001+ employees
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Keeley Wettan
Senior Vice President, Legal
Patrick Loerch
Senior Vice President, Clinical Data Science
Recent News
2025-12-30
BioWorld Financial Watch
2025-12-29
Company data provided by crunchbase